- Resource
- BR1DGE
- Infographic
- Staging
The T1D Early Detection Toolkit
This is a practical guide to establishing islet autoantibody screening programs
Learning Objectives
The T1D Early Detection Toolkit is a collaboration with external experts and organizations to create a clear, practical resource for healthcare professionals who wish to start T1D screening programs.
This toolkit aims to:
- Summarize the latest scientific knowledge and real-world experience in an accessible, step-by-step format
- Provide clinicians with straightforward guidance that can be easily adapted according to local resources, healthcare structures, and clinical pathways
EDENT1FI (European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception)
This work is supported by the Innovative Health Initiative under grant agreement No. 101132379 (EDENT1FI). This Joint Undertaking receives support from the European Union’s Horizon Europe research and innovation program, from The Leona M. and Harry B. Helmsley Charitable Trust, from Breakthrough T1D, from EFPIA, from COCIR, from Vaccines Europe, from EuropaBio and from MedTech. Additional funding is provided to associated UK partners through the UK Research and Innovation (UKRI) Guarantee Fund.
EDENT1FI is funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.
INNODIA
INNODIA is an international non-profit organization providing specialized services to medicine developers focused on curative therapies for people living with type 1 diabetes (T1D). These services are delivered through its network of members and INPACT associates (the trained community of people living with T1D).
.svg){kind=small}
MAT-GLB-2503844 – 1.0 - 10/2025
A Conversation About Early T1D
An expert discussion on presymptomatic T1D, with a focus on early detection, monitoring, and management, featured in a North European webinar (October 2025).
BR1DGE Podcast Episode 6
Partha Kar talks to Jurgen Vercauteren, a T1D researcher living with T1D, about the challenges and benefits of screening for early-stage T1D
BR1DGE Podcast Episode 5
Partha Kar talks to Mike Natter, an endocrinologist with type 1 diabetes, about how art and social media can be leveraged to engage and educate the wider diabetes community.